Ara
Toplam kayıt 3, listelenen: 1-3
Fingolimod for the treatment of relapsing-remitting multiple sclerosis
(Turkish Neurological Society, 2017)
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approved ...
Myelin disorders and stem cells: As therapies and models
(Tubitak Scientific & Technical Research Council, 2016)
Myelin disorders burden millions of people around the world, yet existing therapies are inadequate to cure them. Current remedies commonly treat the symptoms with minimal to no effect on the actual cause of the disorder. ...
Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: Current status and applications
(Taylor & Francis Ltd, 2021)
Neurodegeneration is defined as the progressive atrophy and loss of function of neurons; it is present in neurodegenerative disorders such as Multiple Sclerosis, Alzheimer's, Huntington's, and Parkinson's diseases. The ...